Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
暂无分享,去创建一个
Michael J. Grusby | Mary Collins | Bruce A. Jacobson | Takashi Tanaka | M. Collins | M. Whitters | M. Grusby | S. Goldman | D. Donaldson | J. Sypek | Takashi Tanaka | M. Kasaian | Nancy Wood | Matthew J. Whitters | JoAnn Witek | Joseph P. Sypek | Marion Kasaian | Michael J. Eppihimer | Michelle Unger | Samuel J. Goldman | Debra D. Donaldson | J. Witek | M. Eppihimer | B. A. Jacobson | N. Wood | Michelle J. Unger
[1] D. Cockayne,et al. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. , 1997, Journal of immunology.
[2] D D Donaldson,et al. Interleukin-13: central mediator of allergic asthma , 1998 .
[3] T. Mosmann,et al. Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis. , 1996, Journal of immunology.
[4] T. Wynn,et al. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. , 1999, The Journal of clinical investigation.
[5] R. Fernandez-Botran,et al. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins , 1991, The Journal of experimental medicine.
[6] T. Wynn,et al. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. , 1999, Journal of immunology.
[7] F. Nicoletti,et al. Prevention of endotoxin‐induced lethality in neonatal mice by interleukin‐13 , 1997, European journal of immunology.
[8] Bryan R. G. Williams,et al. Protein-tyrosine Phosphatase Shp-1 Is a Negative Regulator of IL-4- and IL-13-dependent Signal Transduction* , 1998, Journal of Biological Chemistry.
[9] R. Coffman,et al. Modulation of murine macrophage function by IL-13. , 1993, Journal of immunology.
[10] D D Donaldson,et al. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. , 1999, Current opinion in immunology.
[11] R. Strieter,et al. Expression and Contribution of Endogenous IL-13 in an Experimental Model of Sepsis1 , 2000, The Journal of Immunology.
[12] C. Bogdan,et al. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. , 1997, Journal of immunology.
[13] A. Sher,et al. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.
[14] D D Donaldson,et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. , 1998, Journal of immunology.
[15] R. Puri,et al. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. , 1998, Blood.
[16] J. Lélias,et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. , 1996, The Journal of biological chemistry.
[17] S. McKnight,et al. Components of a Stat recognition code: evidence for two layers of molecular selectivity. , 1995, Immunity.
[18] G. Zurawski,et al. Receptors for interleukin‐13 and interleukin‐4 are complex and share a novel component that functions in signal transduction. , 1993, The EMBO journal.
[19] S. Akira,et al. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. , 1996, Journal of immunology.
[20] M. Wills-Karp. Immunologic basis of antigen-induced airway hyperresponsiveness. , 1999, Annual review of immunology.
[21] R. Puri,et al. cDNA Cloning and Characterization of the Human Interleukin 13 Receptor α Chain* , 1996, The Journal of Biological Chemistry.
[22] W. Wisden,et al. Interleukin (IL)-4–independent Induction of Immunoglobulin (Ig)E, and Perturbation of T Cell Development in Transgenic Mice Expressing IL-13 , 1998, The Journal of experimental medicine.
[23] T. Mosmann,et al. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production. , 1999, Journal of immunology.
[24] R. Puri,et al. Interleukin-13 Receptor α′ But Not α Chain: A Functional Component of Interleukin-4 Receptors , 1998 .
[25] F. Finkelman,et al. Stat6 Regulation of In Vivo IL-4 Responses1 , 2000, The Journal of Immunology.
[26] R. de Waal Malefyt,et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] D B Corry,et al. Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.
[28] G. McKenzie,et al. Impaired development of Th2 cells in IL-13-deficient mice. , 1998, Immunity.
[29] A. Mantovani,et al. IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. , 1997, Journal of immunology.
[30] A. Mantovani,et al. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells , 1995, The Journal of experimental medicine.
[31] R. Puri,et al. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. , 2001, Blood.
[32] F. Finkelman,et al. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. , 1998, Immunity.
[33] T. Wynn,et al. Regulation and Function of the Interleukin 13 Receptor α 2 During a T Helper Cell Type 2–dominant Immune Response , 2003, The Journal of experimental medicine.
[34] J. Langhorne,et al. The immune response to Plasmodium chabaudi malaria in interleukin‐4‐deficient mice , 1994, European journal of immunology.
[35] S. Gordon,et al. Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ , 1994, European journal of immunology.
[36] J. Lélias,et al. Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α Chain* , 1996, The Journal of Biological Chemistry.
[37] F. Finkelman,et al. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. , 1993, Journal of immunology.
[38] K. Bost,et al. In vivo treatment with anti‐interleukin‐13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice , 1996, Immunology.
[39] J. G. Zhang,et al. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Moritz,et al. Identification, Purification, and Characterization of a Soluble Interleukin (IL)-13-binding Protein , 1997, The Journal of Biological Chemistry.